ALR yields 151.52% · JNJ yields 2.13%● Live data
📍 ALR pulled ahead of the other in Year 1
Combined, ALR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALR + JNJ for your $10,000?
AlerisLife Inc. operates and manages senior living communities in the United States. It operates through two segments, Residential and Lifestyle Services. Its senior living communities comprise independent living communities, assisted living communities, memory care, continuing care retirement communities (CCRCs), skilled nursing facilities (SNFs), and an active adult community. The company offers nursing and healthcare services; and outpatient rehabilitation clinics and fitness services. As of December 31, 2021, it owned and operated or managed, 141 senior living communities located in 28 states with 20,105 living units, including 10,423 independent living apartments, 9,636 assisted living suites, which includes 1,872 of Bridge to Rediscovery memory care units, and one continuing CCRC, with 106 living units, including 46 SNF. The company was formerly known as Five Star Senior Living Inc. and changed its name to AlerisLife Inc. in January 2022. AlerisLife Inc. was incorporated in 2001 and is headquartered in Newton, Massachusetts.
Full ALR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.